AxoGen Inc reports results for the quarter ended in December - Earnings Summary

AxoGen

14/03/2023 13:32

* AxoGen Inc  AXGN.OQ  reported a quarterly adjusted loss
of 3
cents​​ per share for the quarter ended in December. The mean
expectation of five analysts for the quarter was for a loss
of 11 cents per share.
    * Revenue rose 14.7% to $36.16 million from a year ago;
analysts
expected $36.20 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 13
cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AxoGen Inc shares had fallen by 24.5% this quarter.
    * The company reported a quarterly loss of $5.42 million.
    * Wall Street's median 12-month price target for AxoGen Inc
is
$16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 14 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.11          -0.03          Beat
 Sep. 30 2022      -0.12          -0.01          Beat
 Jun. 30 2022      -0.14          -0.06          Beat
 Mar. 31 2022      -0.15          -0.20          Missed